We are Sterling Bio Machines, a startup developing a novel bioreactor system that will revolutionize how biomanufacturing processes operate and scale.
Introduction
Biomanufacturing is an essential manufacturing process that uses biological systems to produce commercially important products like medicines, materials, food, fuel, chemicals, and more.
At the core of biomanufacturing is the bioreactor, where cells are grown and the biological product is cultivated.
Challenges
Historically, most bioreactors aim to serve the pharmaceutical industry with high value, low volume products, and large R&D budgets for process development and scaling.
Scalability
These machines provide low yield and are difficult to scale. This creates numerous problems that inhibit innovation in biomanufacturing and the products it can produce.
“As much as 60 percent of the physical inputs to the global economy could, in principle, be produced biologically…”
Chui, M., Evers, M., Manyika, J., Zheng, A., & Nisbet, T.
McKinsey, 2020
Prev
Next
Sterling Bio Machines
Our system combines hardware and software to reduce the costs of production, improve resource efficiency, and shorten the time to reach commercial production for biomanufacturing products.
We anticipate that our designs will also enable the use of new cell cultures that are incompatible with existing bioreactors.
About Us
Sterling Bio Machines is led by a dynamic duo, Akshaya & Steve. Akshaya, our CTO, is a pioneer in multi-material 3D printing and bioreactor development, with patent applications in surgical robots and dialysis machines. Steve, our CEO, is an experienced entrepreneur who founded Interfolio, a company that positively impacted the success of over 500 global institutions and millions of scholars.
Together, their diverse expertise in engineering, biotech, enterprise software, and scaling companies makes them the perfect team to drive our mission of revolutionizing the bioeconomy for a healthier, more sustainable world.
